RE: The axe has fallen22 Jan 2024 10:30
Sorry mate-I missed that so -apologies.I have no connection and I’m under restrictive covenant in the space anyway.
I learned a lot about the space from a standing start a few years ago and sold a company that was in the applications side.
What did I learn?Johnson Matthey exiting the space a few years ago was a massive red flag-highlighting the lack of margin in cell manufacture and the fact that billions were being spent on chemistry innovation.
When I was selling, I remember one of the suitors saying very clearly that there were good pickings to be had in the sector but you had to be smart.He was absolutely right-cells constitute a high proportion of the bill of materials in most applications so even further up the supply chain, margins were pretty low-in our case around 25pc
So AMTE in my opinion fell into the trap of trying to manufacture in a low margin environment, looking to sell into notoriously difficult automotive and energy storage OEMs-therein lies the fundamental problem with this company.
Anyway good luck all-there is nothing here for equity